Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Peloton Interactive, Inc. Reports First Quarter Fiscal 2025 Financial Results
-
LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024
-
Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical
-
The Cree Hunters Economic Security Board, 16 Mining & Exploration Companies Contribute $750,000 For The Reconstruction Initiative Forest Fires Fund 2023, James Bay, Quebec
-
Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement
-
Allegro MicroSystems Reports Second Quarter 2025 Results
-
Norwegian Cruise Line Holdings Reports Strong Third Quarter 2024 Financial Results
-
NRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule
-
Nurix Therapeutics to Participate in Upcoming Investor Conferences
-
Majority of Canadians not confident the federal government is committed to making life more affordable: Reducing payroll taxes would relieve some pressure
-
Enviri Corporation Reports Third Quarter 2024 Results
-
Avadel Pharmaceuticals Announces Favorable Ruling in Administrative Procedure Act Litigation
-
Giyani Reinforces Community Engagement in Kanye
-
Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial Results and Provides Corporate Updates
-
Atea Pharmaceuticals to Host Third Quarter 2024 Financial Results Conference Call on November 7, 2024
-
OneWater Marine Inc. Announces Fiscal Fourth Quarter and Full-Year 2024 Earnings Release Date and Conference Call Information
-
Breckenridge Brewery and University of Colorado Athletics Collaborate on New Limited-Edition Craft Beer
-
Aduro Clean Technologies Reports Fiscal 2025 First Quarter Results
-
Thumzup Reveals Plans for Significant Advertiser Growth Over the Next Year
-
Cipher Mining Provides Third Quarter 2024 Business Update
-
Travere Therapeutics Reports Third Quarter 2024 Financial Results
-
Bombardier Celebrates 100th Challenger 3500 Aircraft Delivery, Underscoring Continued Success as Best-Selling Platform
-
Peloton Appoints Peter Stern as CEO and President
-
Macerich Declares the Quarterly Dividend on Its Common Shares
-
BIG3 and Sport Trinity Announce Settlement, Celebrate Renewed Commitment to Basketball Community
-
Bitfarms Enters into Second 10,000 Miner Hosting Agreement with Stronghold Digital Mining
-
Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024
-
Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2024 Financial Results
-
ENGIE and Meta announce 260 MW renewable energy agreement
-
Sandy Spring Bancorp Declares Quarterly Dividend
-
We should all ditch the clocks, or at the very least Daylight Saving: York University expert
-
C4 Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
-
BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease Program
-
Malibu Boats, Inc. Announces First Quarter Fiscal 2025 Results
-
SAB BIO CEO to Participate in Fireside Chat at Guggenheim Securities Healthcare Innovation Conference
-
Climb Bio to Present at Upcoming Investor Conferences
-
PyroGenesis Schedules Third Quarter 2024 Financial Results and Business Update Conference Call
-
GXO Releases 2024 Global Beauty Report
-
BRT Apartments Corp. Announces Filing Date for Third Quarter 2024 Earnings Results
-
Total voting rights
-
OTC Markets Group Welcomes Brazilian Rare Earths Ltd. to OTCQX
-
Study Finds New Digital Products Offer Billions in Revenue Potential by Helping Protect Elderly from Fraud
-
Man Group PLC : Form 8.3 - TI Fluid Systems plc
-
Man Group PLC : Form 8.3 - International Paper Company
-
HSBC Bank PLC: Pre Stabilisation Notice
-
Kimco Realty® Announces Third Quarter 2024 Results
-
Gildan Reports Record Third Quarter Revenue and Adjusted Diluted EPS¹ and Updates its Full Year 2024 Guidance
-
Teleflex Announces Quarterly Dividend
-
Agios Reports Business Highlights and Third Quarter 2024 Financial Results
-
Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction
